Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Torcetrapib/atorvastatin fixed-combination versus atorvastatin or placebo in mixed dyslipidemia
2004-000139-27Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in combined dyslipidaemia, hypercholesterolemia and dyslipidemia comparing Torcetrapib + atorvastatin fixed combination, Atorvastatin alone and Placebo (3 arms). Primary endpoints: Percent change in HDL-C from baseline to follow-up and Percent change in LDL-C from baseline to follow-up. Started Jul 2004; status: completed.
02
Drugs
rocacetrapibatorvastatin
03
Conditions
combined dyslipidaemiahypercholesterolemiadyslipidemia
Beyond the preview
Go deeper on 2004-000139-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000139-27.